price transparency
publication date
Innovation
Medicare Advantage Plans Given Negotiating Power on Part B Drug Prices
The plan does not expand negotiating powers directly to the federal government and Part D drugs, which prompted one critic...
Clinical Care
5-Part Approach to Procuring Hip and Knee Implants
IU Health has a five-pronged strategy for hip and knee implant procurement, featuring pricing, contracting, physician engagement, vendor relations, and...
Finance
Azar: Drug Importation May Not Be a Gimmick After All
There may be 'safe, select avenues for importation' that the U.S. government should consider, the HHS secretary said.
Finance
FDA Biosimilar Action Plan Aims for Affordability Through Competition
Commissioner Scott Gottlieb advocated for the plan during a Brookings Institution presentation.
Finance
Rural Providers Show Support for 340B in Drug Pricing Blueprint
On the final day for public comment on the Trump administration's blueprint to lower prescription drug prices, rural providers and...